Science AI Journal
Neuroscience · Research topic

Open research questions in Neuroinflammation and Neurodegeneration Mechanisms

106 unresolved questions extracted from the limitations and future-work sections of 441 Neuroinflammation and Neurodegeneration Mechanisms papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Long-lasting type 2 immunity elicited by intestinal helminth infections can modify immune responses and wound repair locally and in peripheral tissues, but direct effects of helminth infection on the CNS are poorly understood.

    Helminth infection induces neuroimmune remodeling and clinical remission in a mouse model of multiple sclerosis 2260051 · 2026 · DOI

  • Although rrHSP70 may promote OLG matura- tion to support remyelination, the precise mechanism by which rrHSP70 promotes OLG maturation and functional validation of remyelination, such as behavioral motor assessments or electro- physiological analyses, remain to be investigated.

    Recombinant rat heat shock protein 70 (rrHSP70) may promote remyelination by regulating microglia/macrophages and oligodendrocytes in a toxin-induced demyelination animal model · 2026 · DOI

  • Future research should focus on elucidating the specific mechanisms underlying TREM2 signaling, its interactions with other immune pathways, and how it modulates immune responses across different diseases (153).

    Revisiting TREM2: from multi-omics signaling networks to clinical translation · 2026 · DOI

  • Conclusion This work provides foundational insight into Ft-mediated neuroinflammation and supports further investigation into mechanisms of blood-brain barrier (BBB) disruption and bacterial persistence within the CNS.

    Neuroinflammatory Responses in Glial-Immune Interactions to Francisella tularensis in the Central Nervous System microenvironment 2267481 · 2026 · DOI

  • Rubicon ( Rubcn ), a Beclin1 interacting protein that suppresses autophagy and mediates LC3-associated phagocytosis and endocytosis (LAP/LANDO), influences inflammatory signaling in metabolic, neurodegenerative, and inflammaging diseases; yet its role in acquired brain injury has not been examined.

    Rubicon modulates neuroimmune responses following traumatic brain injury · 2026 · DOI

  • Alzheimer's disease (AD) is one of the most common neurodegenerative disorders, yet the environmental drivers that accelerate its progression remain poorly defined.

    Diesel exhaust particles disrupt mouse and human iPSC-derived microglial function and Amyloid-beta clearance in Alzheimer's disease models · 2026 · DOI

  • Nevertheless, peripheral macrophage engraftment into the brain has been reported, but the biological variables governing central nervous system (CNS) macrophage niche access remain unclear.

    The brain-meningeal interface functions as a reservoir and entry site for brain parenchymal macrophages · 2026 · DOI

  • Subarachnoid haemorrhage (SAH), when blood enters between the meningeal layers that cover the brain, is associated with neuroinflammation, which has been shown to play a critical role in subsequent brain damage; however, the impact of the activation of border-associated immune cells on the pathomechanism of the disease has not been investigated.

    Simultaneous activation of border-associated immune cells and glial cells at the CNS-meningeal interface after subarachnoid haemorrhage in rats · 2026 · DOI

  • Current knowledge is derived predominantly from experimental models and observational clinical stud- ies, both of which provide important mechanistic and epi- demiological insights but remain insufficient to establish causality with certainty. Although the lung–brain axis has emerged as a valuable framework for understanding the relationship between respiratory and neurological health, the available evidence remains limited by several methodological and conceptual constraints.

    The lung–brain axis in neurodegeneration: inflammatory, immune, and vascular mechanisms with therapeutic implications · 2026 · DOI

  • Although the lung–brain axis has gained increasing atten- tion in recent years, the field remains at a relatively early stage of development. Future studies should move beyond mainly observational and cross-sectional findings and focus more on longitudinal and mechanistic approaches to deter- mine whether pulmonary dysfunction contributes directly to the development of neurodegenerative diseases or mainly influences disease progression. One important direction for future research will be the integration of respiratory assess- ment, environmental exposure data, inflammatory biomark- ers, and neuroimaging within the same study populations. Such approaches may provide a clearer picture of how pulmonary inflammation and systemic immune responses affect the brain over time. At the cellular level, additional work is needed to bet- ter understand the role and heterogeneity of microglia in this process. Newer techniques, including single-cell RNA sequencing and spatial transcriptomics, may help iden- tify distinct neuroinflammatory signatures associated with chronic lung disease and systemic inflammation. These findings could eventually contribute to the identification of more targeted therapeutic strategies. Extracellular vesicles, particularly exosomes, also rep- resent an area of growing interest. Their potential role in transporting inflammatory and molecular signals from the lungs to the brain may offer new insights into inter-organ communication and may support the development of novel biomarkers for early detection and disease monitoring. From a clinical perspective, future studies should con- sider respiratory dysfunction, air pollution exposure, and systemic inflammation as biologically relevant contributors rather than secondary variables. It will also be important to investigate whether interventions targeting pulmonary inflammation, oxidative stress, or environmental exposures can influence neurological outcomes in patients at risk of neurodegenerative disease. Thus, continued progress in this field will require closer collaboration between neurology, pulmonology, biochem- ists, immunology, and environmental health researchers. Whereas, A more extensive understanding of the lung–brain axis may ultimately support earlier and more preventive approaches to neurodegenerative disease management.

    The lung–brain axis in neurodegeneration: inflammatory, immune, and vascular mechanisms with therapeutic implications · 2026 · DOI

  • In the brain, PLC{gamma}2 is expressed in microglia, and other neuroimmune and vascular interface populations, yet its role in brain homeostasis remains incompletely defined.

    PLCγ2 deficiency compromises systemic immune tolerance and erodes myelin homeostasis while enhancing oxidative metabolism in the mouse brain · 2026 · DOI

  • Neurodegeneration is a major determinant of disability progression in multiple sclerosis (MS), yet the pathophysiological mechanisms associating inflammation to neuronal insult remain poorly understood.

    Synaptic and Extrasynaptic NMDA Receptors Oppositely Regulate Dendritic Syntaphilin Intrusion in Multiple Sclerosis · 2026 · DOI

  • These results reveal DSI as a potential mechanistic link between inflammatory signaling and excitotoxic neuronal injury and indicate that modulation of GluN2B-dependent pathways warrants further investigation in inflammatory neurodegenerative disorders.

    Synaptic and Extrasynaptic NMDA Receptors Oppositely Regulate Dendritic Syntaphilin Intrusion in Multiple Sclerosis · 2026 · DOI

  • PND arise not from surgical inflammation alone, but from a mismatch between acute perioperative immune challenge and a pre −existing, microglia−centered brain immune landscape. This land- scape is shaped by aging, preoperative cognitive impairment, comorbidities, and prior inflammatory exposure, and it determines the threshold for inflammatory initiation, the mode of amplifica- tion, and the capacity for resolution. Microglia serve as central integrators of peripheral−to−central immune signals, yet their perioperative responses are not binary but lie along a dynamic continuum of states. In a primed or vulnerable brain, microglia exhibit lower activation thresholds, exaggerated effector programs, and impaired resolution capacity—states sustained by durable reprogramming mechanisms including mitochondrial dysfunction, glycolytic bias, epigenetic remodeling, and trained immunity−like memory. These cell−intrinsic changes, together with multicellular interactions involving astrocytes, vascular cells, and infiltrating immune cells, determine whether postoperative neuroinflammation resolves or persists, leading to synaptic loss, network dysfunction, and heterogeneous cognitive outcomes. This framework explains why broad anti−inflammatory strategies often fail and argues instead for time−window−specific and state−dependent interven- tions: reducing preoperative priming and enhancing cognitive reserve, limiting intraoperative triggers, and actively promoting postoperative resolution and repair. Future research should prioritize longitudinal, high−resolution mapping of microglial state trajectories across perioperative time points, combined with causal testing of metabolic and epigenetic reprogramming pathways such as mitochondrial quality control, glycolysis, histone modification, and trained immunity. Equally im- portant is the dissection of multicellular networks in vivo, moving beyond a microglia−centric view to include astrocytes, endothelium, and peripheral immune cells. For clinical translation, biomarkers that reflect microglial homeostatic loss, metabolic reprogramming, or resolution capacity are urgently needed to stratify patients and enable time−locked, biomarker−guided trials. Finally, experimental models must systematically incorporate clinically relevant modifiers— aging, diabetes, obesity, hypertension, and preoperative cognitive impairment-as core determinants of the baseline immune landscape. By reframing PND as a disorder of microglial state transitions and resolution failure, this integrated perspective offers a roadmap for precision perioperative medicine aimed at preserving cognitive resil- ience and restoring neural network homeostasis.

    Perioperative neurocognitive disorders as a neuroimmune landscape disorder: microglial priming, state heterogeneity, and time-dependent neuroinflammation · 2026 · DOI

  • Whether other CSF1R inhibitors, particularly the FDA-approved PLX3397, exert systemic metabolic effects that may influence the interpretation of brain phenotypes remains unknown.

    PLX3397 Reshapes Hepatic Lipid Metabolism Independent of Microglial Depletion · 2026 · DOI

  • The rare R47H variant of the microglial TREM2 gene increases Alzheimers disease (AD) risk, but its effects on early hippocampal circuitry remain unclear.

    The Microglial Trem2 R47H Alzheimer's Disease Risk Variant Does Not Detectably Alter Hippocampal Synaptic Transmission in Young Mice · 2026 · DOI

  • Neuroinflammation is a hallmark of Alzheimers disease (AD), yet the molecular mediators driving microglial dysfunction and neurotoxicity remain poorly understood.

    Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processing · 2026 · DOI

  • Significance StatementNeuroinflammation and amyloid-beta (A{beta}) plaques drive Alzheimers disease progression, but the molecular bridges between plaque formation, microglial dysfunction, and neurodegeneration remain unclear.

    Galectin-3 drives neuroinflammatory amyloid remodeling by stabilizing intermediate Aβ species and altering lysosomal processing · 2026 · DOI

  • While OMT has garnered increasing attention as a potential neuroinflammation therapeutic, its precise mechanisms of action remain poorly characterized.

    Oxymatrine suppresses neuroinflammation via promoting microglial M2 polarization through FTO-dependent m6A demethylation of PGC-1α mRNA · 2026 · DOI

  • Lastly, we will close with implications of OAHI that warrant further study, including the future epidemiologic impact on related cognitive disorders in the wake of the opioid epidemic and potential therapeutic applications of opioid antagonism for mild cognitive impairment.

    Opioid‐Associated Hippocampal Injury: Past, Present, and Future Directions · 2026 · DOI

  • Several limitations of this study should be acknowledged. First, while microglial identity was robustly demonstrated at the protein level using a discriminatory marker panel and validated with THP-1 mac- rophages as positive controls, this was a single-modality approach. For a broader multimodal perspective, flow cytometry or transcriptomic profiling would further refine the assessment of cellular purity and provide population-level molecular characterization. Second, CD68 intensity was used as a surrogate marker of lysosomal and phagocytic activity; however, direct functional assays such as fluorescent bead uptake or cytokine secretion measurements would be required to con- firm functional consequences of the observed protein-level changes. The discrepancy between CD68 mRNA and protein levels remains unresolved and may reflect post-transcriptional regulatory mecha- nisms that warrant further investigation. Third, the mechanistic rela- tionship between OPN and its putative receptors, CD44 and integrins, was not directly assessed in this study. Prior research has demonstrated OPN-mediated regulation of CD44 expression through integrin signal- ing pathways, as well as loss of CD44-dependent functions following OPN knockout in macrophages (Marroquin et al., 2004; Zhu et al., 2004). Receptor-level perturbation experiments would be necessary to establish causality in hiPSC-derived microglia. Finally, hiPSC-derived microglia, while recapitulating key features of brain-resident microglia, may exhibit subtle phenotypic differences compared to primary human microglia isolated from brain tissue (Paolicelli et al., 2022). The mor- phological and marker-based observations presented here provide descriptive evidence of microglial responses and should be interpreted as hypothesis-generating findings that warrant validation through mul- timodal analyses beyond staining techniques.

    Microglia derived from human induced pluripotent stem cells are regulated by osteopontin, an endogenous extracellular matrix protein maintaining immune homeostasis · 2026 · DOI

  • BackgroundImmune-mediated mechanisms are increasingly implicated in childhood arterial ischemic stroke (AIS), but the associated inflammatory pathways and how they differ by stroke subtype and outcome remain poorly understood.

    Post-stroke Innate Immune Dysfunction in Childhood Arterial Ischemic Stroke: Transcriptomic Signatures Distinguish Etiologies and Outcomes · 2026 · DOI

  • Interleukin‐4 (IL4) has shown beneficial abilities to re‐establish microglial homeostasis in experimental models of CNS traumatic injury, stroke and multiple sclerosis, but its optimal administration system remains uncertain.

    Extracellular Vesicle‐Associated IL4 Displays Enhanced Anti‐Inflammatory Properties in Microglial Cells · 2026 · DOI

  • ABSTRACT Interleukin‐1 (IL‐1) signaling is a major driver of post‐ischemic neuroinflammation, yet the cell‐ and isoform‐specific roles of the two major IL‐1 receptor type 1 agonists, IL‐1α and IL‐1β, remain incompletely defined in the context of stroke.

    Specific Deletion of Interleukin‐1 Beta in Microglia Improves Acute Outcome and Modulates Neurogenesis After Ischemic Stroke · 2026 · DOI

  • These results indicate that moderate microglial alterations in the Shank3 mouse model may be circuit-dependent rather than a global phenomenon across all sensory modalities, warranting further investigation into the interplay between glial cells and sensory circuit dysfunction.

    Region-specific microglial alterations in the acoustic startle circuit in Shank3 mice · 2026 · DOI

Most-cited papers in Neuroinflammation and Neurodegeneration Mechanisms

Most recent work

Find a gap in your own Neuroinflammation and Neurodegeneration Mechanisms sub-topic

This page shows what the Neuroinflammation and Neurodegeneration Mechanisms literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Neuroscience

Autism Spectrum Disorder Research
687 open questions
Neural and Behavioral Psychology Studies
178 open questions
Functional Brain Connectivity Studies
148 open questions
Memory Processes and Influences
136 open questions
Hearing Loss and Rehabilitation
131 open questions
Neurobiology of Language and Bilingualism
116 open questions
Psychology of Moral and Emotional Judgment
115 open questions
Neuroscience and Music Perception
98 open questions
106 open questions have been extracted from the limitations and future-work passages of 441 Neuroinflammation and Neurodegeneration Mechanisms papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.